Invited article (0.3M)	Narchi H*, Kulaylat N**. Heart disease in infants of diabetic mothers. Images Paediatr Cardiol 2000;3:17-23
*	Consultant Paediatrician, Paediatric Department, Sandwell General Hospital, Lyndon, West Bromwich, West Midlands B 71 4HJ, United Kingdom
**	Consultant Paediatrician, Paediatric Unit, Saudi Aramco Al Hasa Health Center, Box 6030, Mubarraz 31311, Saudi Arabia

Article

Introduction
The risk of congenital anomalies is increased in infants of diabetic mothers (IDM), and is estimated to be between 2.5 to 12%, with an over-representation of congenital heart defects. ^1,2 The incidence of malformations is the highest in the group where mothers were on insulin at the time of conception.¹ IDMs often develop respiratory problems which need to be differentiated from the cardiovascular problems they are prone to have (structural congenital heart defect and hypertrophic cardiomyopathy) and from cardiovascular maladaptation to extra-uterine life which they may also suffer.^3,4

1. Structural cardiac malformations
Congenital heart disease occurs in 5% of IDM. The highest relative risk for major cardiovascular defects occurs if the mother has gestational diabetes and develops insulin resistance in the 3^rd trimester. It is thought that maternal diabetes, via its effects on maternal metabolism, is responsible for the increase of malformations in the offspring.⁵ However, using hemoglobin A1c values as an indicator of maternal diabetic control, other studies have shown that congenital heart disease in the fetus is not significantly related to maternal diabetic control.⁶ The most frequent cardiac anomalies in IDMs include ventricular septal defect, transposition of great arteries and aortic stenosis. Defects involving the great arteries, including truncus arteriosus and double outlet right ventricle, are also more prevalent in IDMs.^7,8

The clinical presentation, diagnostic approach and therapy depend on the type of structural heart disease present, and are no different from when they occur in neonates born to non-diabetic mothers.

2. Cardiovascular adaptation to extrauterine life
In IDM with respiratory distress, the right ventricular pre-ejection period to ventricular ejection time ratio is elevated, suggesting an abnormality of the transitional pulmonary circulation.³ The closure of the ductus arteriosus and postnatal decrease in pulmonary artery pressure are also delayed in these neonates.⁴ This may partially explain the frequent occurrence of respiratory problems and the slowness of the recovery in such infants. Primary pulmonary hypertension may be associated with and aggravated by the polycythemia which is also frequently present in these neonates.

3. Hypertrophic cardiomyopathy
3.1 While symptomatic hypertrophic cardiomyopathy (HC) occurs in 12.1% of IDM, when routinely searched for with an echocardiographic scan it is found in 30%.⁹ The left ventricular mass and contractility are increased and there is left ventricular outflow tract (LVOT) obstruction with apposition of the anterior leaflet of the mitral valve to the interventricular septum during systole. Cardiac output is significantly reduced, secondary to reduced stroke volume and is directly related to the degree of septal hypertrophy.¹⁰ This asymmetric septal enlargement, with a disproportionally hypertrophic septum, is an anabolic result of fetal hyperinsulinemia triggered by maternal hyperglycemia during the third trimester. Cardiac septum hypertrophy correlates with maternal glycosylated haemoglobin levels and high levels of fetal insulin better than with macrosomia (fig. 1).
 

3.2 The severity of IDM cardiomyopathy can vary from an incidental finding on echocardiography (30% of cases) to an infant with severe symptoms of congestive heart failure (12% of cases).¹¹ HC is usually benign and consists of systolic murmur and transitory cardiomegaly. All symptoms usually spontaneously regress within a few weeks. Sometimes, overt congestive heart failure develops, with tachypnea, tachycardia, gallop rhythm and hepatomegaly.

3.3 Cardiomegaly is invariably present radiologically when HC is symptomatic, with pulmonary congestion (fig 2). The electrocardiographic findings are not usually helpful.
 

3.4 The natural history of HC is that of spontaneous regression of symptoms and septal hypertrophy.¹⁵ Most of the infants need only supportive care, with fluid restriction, diuretics and oxygen. Digoxin and inotropes are contraindicated as they increase LVOT obstruction. If pharmacologic intervention is deemed necessary, beta adrenergic blocking agents such as propranolol, are the drugs of choice, as they reduces heart rate, left ventricular contractility and wall stress, with total relief of symptoms obtained with standard doses of propranolol in 30% of affected infants.^15,16

3.5 The natural history of HC is benign, with resolution of symptoms within two to four weeks and resolution of septal hypertrophy during the first 2 to 12 months of life, irrespective of therapy. ^14,15 Early or progressive hypertrophy of the LV posterior wall is a predictor of poor outcome, regardless of associated disease.¹⁷

Antenatal diagnosis
With congenital heart disease occuring in up to 5% of fetuses of diabetic mothers, and with 90% of the cardiac lesions identifiable prenatally, it has been suggested that detailed fetal echocardiography is offered to all diabetic women during pregnancy.^18-22 However, when studied in relation to maternal initial HbA1c, the overall sensitivity for identifying congenital heart disease was 50% and specificity 54% and no critical level of HbA1c that provided optimal predictive power for congenital heart disease screening was identified.²³ It has also been suggested that the fetal cardiac septum thickness should be measured in utero by sonocardiography in all diabetic pregnancies.²⁴

Prevention
Careful management of diabetes in pregnancy may reduce the severity of hypertrophic cardiomyopathy.^11,25 However, other studies found no relationships between the echocardiographic results and the metabolic control of pregnancy or fetal characteristics, suggesting that strict maternal diabetes control may not prevent accelerated fetal cardiac growth and abnormal development of cardiac function.^26,27

References

1. Day RE, Insley J . Maternal diabetes mellitus and congenital malformation. Survey of 205 cases. Arch Dis Child. 1976;51:935-8.
2. Ramos-Arroyo MA, Rodriguez-Pinilla E, Cordero JF . Maternal diabetes: the risk for specific birth defects. Eur J Epidemiol 1992;8:503-508
3. Mace S, Hirschfield SS, Riggs T, Fanaroff AA, Merkatz IR . Echocardiographic abnormalities in infants of diabetic mothers. J Pediatr 1979;95:1013-1019
4. Seppanen MP, Ojanpera OS, Kaapa PO, Kero PO . Delayed postnatal adaptation of pulmonary hemodynamics in infants of diabetic mothers. J Pediatr 1997;131:545-548
5. Chung CS, Myrianthopoulos NC . Factors affecting risks of congenital malformations. II. Effect of maternal diabetes on congenital malformations. Birth Defects Orig Artic Ser 1975;11:23-38
6. Gladman G, McCrindle BW, Boutin C, Smallhorn JF . Fetal echocardiographic screening of diabetic pregnancies for congenital heart disease. Am J Perinatol. 1997;14:59-62
7. Adams MM, Mulinare J, Dooley K . Risk factors for conotruncal cardiac defects in Atlanta. J Am Coll Cardiol 1989;14:432-442
8. Ferencz C, Rubin JD, McCarter RJ, Clark EB . Maternal diabetes and cardiovascular malformations: predominance of double outlet right ventricle and truncus arteriosus. Teratology 1990;41:319-326
9. Vural M, Leke L, Mahomedaly H, et al . Should an echocardiographic scan be done routinely for infants of diabetic mothers? Turk J Pediatr 1995;37:351-356
10. Walther FJ, Siassi B, King J, Wu PY . Cardiac output in infants of insulin-dependent diabetic mothers. J Pediatr 1985;107:109-114
11. Reller MD, Kaplan S . Hypertrophic cardiomyopathy in infants of diabetic mothers: an update. Am J Perinatol 1988;5:353-358
12. Gutgesell HP, Mullins CE, Gillette PC, et al . Transient hypertrophic subaortic stenosis in infants of diabetic mothers. J Pediatr 1976;89:120-125
13. Halliday HL . Hypertrophic cardiomyopathy in infants of poorly-controlled diabetic mothers. Arch Dis Child 1981;56:258-263
14. Deorari AK, Saxena A, Singh M, Shrivastava S . Echocardiographic assessment of infants born to diabetic mothers. Arch Dis Child 1989;64:721-4
15. Way GL, Wolfe RR, Eshaghpour E, et al . The natural history of hypertrophic cardiomyopathy in infants of diabetic mothers. J Pediatr 1979;95:1020-1025
16. Lusson JR, Gaulme J, Raynaud EJ, Cheynel J . Hypertrophie septale asymetrique du nouveau-né de mère diabétique. Arch Fr Pediatr 1982;39:433-436
17. Suda K, Kohl T, Kovalchin JP, Silverman NH . Echocardiographic predictors of poor outcome in infants with hypertrophic cardiomyopathy. Am J Cardiol 1997;80:595-600
18. Meyer-Wittkopf M, Simpson JM, Sharland GK . Incidence of congenital heart defects in fetuses of diabetic mothers: a retrospective study of 326 cases. Ultrasound Obstet Gynecol 1996;8:8-10
19. Wheller JJ, Reiss R, Allen HD . Clinical experience with fetal echocardiography. Am J Dis Child 1990;144:49-53
20. Zielinsky P . Role of prenatal echocardiography in the study of hypertrophic cardiomyopathy in the fetus. Echocardiography 1991;8:661-668
21. Cooper MJ, Enderlein MA, Dyson DC, Roge CL, Tarnoff H . Fetal echocardiography: retrospective review of clinical experience and an evaluation of indications. Obstet Gynecol 1995;86:577-582
22. Buskens E, Stewart PA, Hess J, Grobbee DE, Wladimiroff JW . Efficacy of fetal echocardiography and yield by risk category. Obstet Gynecol 1996;87:423-428
23. Shields LE, Gan EA, Murphy HF, Sahn DJ, Moore TR . The prognostic value of hemoglobin A1c in predicting fetal heart disease in diabetic pregnancies. Obstet Gynecol 1993;81:954-957
24. Fenichel P, Hieronimus S, Bourlon F, et al .Macrosomie du foetus de mère diabétique. Presse Med 1990;19:255-258
25. Reller MD, Tsang RC, Meyer RA, Braun CP . Relationship of prospective diabetes control in pregnancy to neonatal cardiorespiratory function. J Pediatr 1985;106:86-90
26. Rizzo G, Arduini D, Romanini C . Accelerated cardiac growth and abnormal cardiac flow in fetuses of type I diabetic mothers. Obstet Gynecol 1992;80:369-376
27. Sheehan PQ, Rowland TW, Shah BL, McGravey VJ, Reiter EO . Maternal diabetic control and hypertrophic cardiomyopathy in infants of diabetic mothers. Clin Pediatr (Phila) 1986;25:266-271